Cash Pay, Ninety Miles From Home

Do:

1. Do not dispense. The pharmacist is the only person who can make the fill/no-fill decision on a controlled substance; you have no authority to release it, and "the system let me" is not a defense.
2. Keep the transaction at intake. Complete data entry, verify the prescriber's DEA registration and state license are active and match the address, confirm the patient's identity, and record what you observed factually (cash payment, distance, prescriber pattern) in a note - not as an accusation, as data.
3. Buy time honestly. "I'm sorry for the wait - the pharmacist needs to review this one personally; it should be about 15 minutes." That is true and does not disclose a suspicion.
4. Have the information ready for the pharmacist - the three prior prescriptions, the PDMP data if the pharmacist can pull it, the prescriber's contact number and hours.

Do not:

• Do not accuse the patient of anything, and do not say the prescription looks forged or that the prescriber is under suspicion.
• Do not state or imply a reason for refusal before the pharmacist decides.
• Do not call the prescriber and tell them you are declining; verification is a question, not an announcement.
• Do not discuss the other patients' prescriptions. That is protected health information and disclosure alone can create liability independent of the fill decision.
• Do not let the patient's impatience move the decision to you. Corresponding responsibility sits with the pharmacist, and the pharmacy's exposure sits with whoever dispensed.

Documentation (written the same day, in the patient/prescription record):

• The specific, observable facts: distance from prescriber, cash payment, quantity and strength, absence of prior relationship with the pharmacy, the pattern with prior prescriptions (by count, not by name).
• The verification attempt: who was called, when, what was asked, what was answered, and who answered.
• The PDMP review if performed, with the date and time.
• The pharmacist's stated clinical rationale and the decision. "Suspicious" alone is not a rationale; "pattern of cash payment, out-of-area prescriber, and PDMP showing three prescribers in 60 days" is.
• What the patient was told and whether they were offered alternatives (e.g., a written notice if your state requires one, and return of the prescription if your law permits).

Limits on communication:

• You may state that the pharmacist is not able to fill the prescription and, if your state requires, provide the reason in the form the law specifies.
• You may offer to speak with the pharmacist directly and give the prescriber's office a factual call-back.
• You may not accuse the patient of a crime, disclose other patients' information, or speculate about the prescriber's conduct.
• If the patient becomes agitated, do not escalate or block the door; involve the pharmacist and follow your workplace-safety policy. A refusal is a professional decision, not a confrontation.

Some states require a specific written notification when a pharmacist declines to fill; know your state's rule, because the documentation standard and the notification duty are separate obligations.

Proposed system:

1. A written red-flag SOP with an explicit list: long distance from prescriber or pharmacy, cash payment for high-cost controlled substances, patterns across patients with the same prescriber, early refills, multiple prescribers, unusual quantities or directions, and patient behavior at intake. The SOP should specify that the technician's job is to surface and document, and the pharmacist's job is to decide.
2. PDMP check built into the intake workflow so it happens at data entry for every controlled substance rather than only when someone feels uneasy. A check that depends on a hunch will be applied inconsistently and will miss the cases where the staff member simply was not suspicious.
3. A verification script for prescriber calls that asks a defined set of questions (diagnosis, prior treatments, whether the prescriber has seen the patient, expected duration), so the outcome is a documented answer rather than a vague impression.
4. Staff training with case scenarios, including how to talk to an upset patient, so the counter conversation is rehearsed rather than improvised.
5. A monthly review of refusals - how many, on what grounds, and whether any patient was subsequently found to have a legitimate need.

The risk of building it wrong: a red-flag list applied without nuance turns into systematic refusal of legitimate pain patients - particularly those who pay cash, live far from a specialist, or are seen at a pain clinic, which disproportionately hits patients with low income or those in rural areas. If refusals are counted but never reviewed, the pharmacy will not see that pattern. Build the review into the SOP from day one, and make the standard "was this decision defensible on the documented facts," not "how many did we turn away."